Home> Products> topbest 200 uses and indications

{ "products": [ { "_id": "6979ab153e3091701b89e481", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Misoprostol Tablet 200 mcg", "description": "MISOPIRATE 200 is a pharmaceutical preparation containing Misoprostol 200 mcg, a synthetic prostaglandin E1 analogue that has revolutionized women's healthcare and gastrointestinal treatment protocols. This medication represents a critical therapeutic option in modern medicine, offering solutions for conditions ranging from gastric ulcer prevention to obstetric and gynecological applications. Each tablet of MISOPIRATE 200 is precisely formulated to deliver consistent therapeutic benefits while maintaining strict quality standards.Misoprostol, the active ingredient in MISOPIRATE 200, was initially developed for protecting the gastric lining but has since become indispensable in reproductive healthcare. The medication works by mimicking natural prostaglandins in the body, which are hormone-like substances that regulate various physiological processes including gastric acid secretion, cervical ripening, and uterine contractions.Mechanism of ActionMISOPIRATE 200 functions through multiple pathways depending on the clinical indication. In the gastrointestinal system, it reduces gastric acid secretion by directly inhibiting parietal cells in the stomach lining. Simultaneously, it enhances the production of protective mucus and bicarbonate, creating a defensive barrier against acid-induced damage. This dual action makes it exceptionally effective in preventing and treating peptic ulcers, particularly those induced by nonsteroidal anti-inflammatory drugs (NSAIDs).In obstetric and gynecological applications, MISOPIRATE 200 acts on prostaglandin receptors in the uterus and cervix. It causes the cervix to soften and dilate while stimulating rhythmic uterine contractions. These properties make it valuable for medical management of early pregnancy complications, labor induction, and postpartum hemorrhage prevention.Clinical Uses and ApplicationsGastric Protection: MISOPIRATE 200 serves as a prophylactic agent for individuals requiring long-term NSAID therapy who are at elevated risk for developing gastric or duodenal ulcers. Patients with rheumatoid arthritis, osteoarthritis, or chronic pain conditions who depend on NSAIDs benefit significantly from concurrent misoprostol therapy.Peptic Ulcer Treatment: The medication accelerates healing of existing gastric ulcers by reducing acid exposure and promoting mucosal regeneration. Treatment typically spans four to eight weeks, depending on ulcer severity and individual response.Medical Management of Early Pregnancy Loss: Under strict medical supervision, MISOPIRATE 200 is utilized for managing incomplete miscarriage or missed abortion, offering a non-surgical alternative that many women prefer for emotional and practical reasons.Labor Induction: In hospital settings, healthcare providers may use MISOPIRATE 200 to ripen the cervix and initiate labor when medically indicated, such as in cases of post-term pregnancy or maternal health concerns.Postpartum Hemorrhage Prevention: The medication's ability to promote uterine contractions makes it valuable in preventing excessive bleeding after childbirth, particularly in resource-limited settings.Key Benefits of MISOPIRATE 200Effective Gastric Protection: MISOPIRATE 200 provides superior protection against NSAID-induced gastric damage compared to many alternatives. Clinical studies demonstrate up to 80% reduction in serious gastrointestinal complications among high-risk patients using preventive misoprostol therapy.Non-Invasive Medical Option: For women facing early pregnancy complications, MISOPIRATE 200 offers a medical alternative to surgical procedures, preserving privacy, reducing healthcare costs, and eliminating surgical risks such as anesthesia complications or uterine perforation.Rapid Onset of Action: The medication demonstrates quick absorption and onset, with effects typically beginning within 30 minutes to two hours, allowing for predictable therapeutic outcomes.Cost-Effectiveness: Compared to surgical interventions or hospitalization for complications, MISOPIRATE 200 represents an economical treatment option, making essential healthcare more accessible to diverse populations.Versatile Clinical Applications: The medication's multiple therapeutic uses make it a valuable tool across different medical specialties, from gastroenterology to obstetrics.Stable Formulation: MISOPIRATE 200 maintains stability across various storage conditions, improving accessibility in regions with limited refrigeration infrastructure.Potential Side Effects and Adverse ReactionsWhile MISOPIRATE 200 is generally well-tolerated, users should be aware of possible side effects:Gastrointestinal Disturbances: Diarrhea occurs in approximately 15-40% of patients, typically mild and self-limiting. Abdominal cramping, nausea, and flatulence are also common, particularly during initial treatment phases.Uterine Effects: Women of reproductive age may experience menstrual irregularities, heavier menstrual flow, or intermenstrual spotting. Uterine cramping is expected when the medication is used for obstetric purposes.Vascular Symptoms: Some patients report headaches, dizziness, or hot flashes, though these are generally transient and mild in nature.Allergic Reactions: Though rare, hypersensitivity reactions including skin rashes, itching, or more serious anaphylactic responses can occur and require immediate medical attention.Serious Complications: When used inappropriately for pregnancy termination outside medical supervision, serious complications including incomplete abortion, severe bleeding, infection, or rupture can occur. This underscores the critical importance of medical oversight.Important Precautions and ContraindicationsMISOPIRATE 200 is absolutely contraindicated during pregnancy when the intention is to continue the pregnancy, as it can cause miscarriage or severe fetal abnormalities. Women of childbearing potential must use reliable contraception during treatment. The medication should not be used by individuals with known allergy to prostaglandins or those with inflammatory bowel disease without careful medical evaluation.Patients with cardiovascular disease, cerebrovascular conditions, or poorly controlled hypertension require careful monitoring when using MISOPIRATE 200. The medication may interact with antacids containing magnesium, potentially exacerbating diarrhea.Dosage and Administration GuidelinesDosing of MISOPIRATE 200 varies significantly based on the clinical indication. For gastric protection, typical regimens involve 200 mcg taken two to four times daily with meals. For obstetric uses, dosing protocols are highly specific and must be determined by qualified healthcare providers based on individual circumstances, gestational age, and medical history.The medication should be taken with food to minimize gastrointestinal side effects. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed otherwise by a healthcare provider.ConclusionMISOPIRATE 200 represents a significant therapeutic advancement in both gastroenterology and reproductive healthcare. Its dual capacity to protect the gastric mucosa and influence uterine function makes it an invaluable medication across multiple clinical scenarios. The proven efficacy in preventing NSAID-induced ulcers has prevented countless cases of serious gastrointestinal bleeding, while its role in women's healthcare has expanded access to safe, effective medical management options.", "price": 85.0, "discountamount": 25.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2287, "imageuri": "https://productimages.withfloats.com/actual/6979ab1bad683d72f6cf0b98.png", "tileimageuri": "https://productimages.withfloats.com/tile/6979ab1bad683d72f6cf0b98.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-28T06:22:13.304Z", "updatedon": "2026-03-14T07:17:15.436Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/misoprostol-tablet-200-mcg/2287", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MISOPIRATE 200", "category": "GYANECOLOGYRANGE", "tags": [ "misoprostol tablet 200 mcg uses", "misoprostol 200 mcg tablet dosage", "misoprostol 200 mcg tablet benefits", "misoprostol tablet 200 mcg composition", "misoprostol 200 mcg tablet how it works", "misoprostol tablet 200 mcg side effects", "misoprostol 200 mcg tablet mechanism of action", "misoprostol tablet 200 mcg price in india", "misoprostol 200 mcg tablet storage instructions", "misoprostol 200 mcg tablet for gastric protection", "misoprostol 200 mcg tablet prostaglandin analog", "misoprostol tablet 200 mcg price in india", "misoprostol 200 mcg tablet administration guide", "misoprostol tablet 200 mcg patient information" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1000.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2026-03-26T06:00:31.59Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "GYANECOLOGYRANGE", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone.", "tab elagolix 200mg", "elagolix 200mg.", "elagolix.", "elagolix 200.", "elagolix tablets", "elagolix tablets uses.", "elagolix 200 mg price.", "elagolix mechanism of action.", "elagolix 200 mg uses.", "tab elagolixtab elagolix." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6937c2a25e5aca52da7cb29f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Favipiravir 200mg", "description": "Favipiravir 200mg is an antiviral medication widely used to treat viral infections, particularly those caused by RNA viruses. It has gained significant attention in recent years as a promising therapeutic agent, especially during viral outbreaks such as influenza and more recently, COVID-19. This detailed description covers the product overview, its uses, key benefits, potential side effects, and a concluding summary to help users better understand Favipiravir 200mg.\n\nProduct Description\nFavipiravir belongs to a class of antiviral drugs that inhibit the replication of RNA viruses by targeting viral RNA-dependent RNA polymerase—an enzyme vital for viral replication. The 200mg dosage formulation is designed for oral administration and is typically available as film-coated tablets. The drug works by interfering with the viral genome synthesis process, thereby limiting the ability of viruses to multiply and spread in the body.\n\nOriginally developed and approved in Japan for the treatment of novel influenza strains, Favipiravir has since been explored and authorized in multiple countries for off-label or emergency use against other viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).\n\nUses of Favipiravir 200mg\nFavipiravir is primarily used as an antiviral treatment for infections caused by RNA viruses. Its key applications include:\n\nInfluenza Treatment: Favipiravir is effective against various strains of influenza viruses, especially when other antiviral medications prove less effective due to resistance or outbreak severity.\n\nCOVID-19 Management: During the COVID-19 pandemic, Favipiravir was rapidly adopted as part of many treatment protocols globally. It is used to manage mild to moderate COVID-19 cases by reducing viral load and accelerating recovery time.\n\nEmerging Viral Diseases: Favipiravir’s broad-spectrum antiviral activity makes it a potential treatment for other emerging RNA virus outbreaks, including Ebola, Lassa fever, and other viral hemorrhagic fevers.\n\nThe drug is typically prescribed by healthcare professionals after confirmed diagnosis and assessment of viral infection severity. Treatment duration and dosage depend on the specific infection and patient profile.\n\nKey Benefits of Favipiravir 200mg\nFavipiravir offers several important benefits that contribute to its growing role in viral infection management:\n\nBroad-Spectrum Antiviral Activity: Favipiravir targets a wide array of RNA viruses, making it versatile for treating multiple infections beyond influenza.\n\nOral Administration: Its oral tablet form facilitates ease of use in outpatient settings, reducing the burden on hospital resources and enabling home-based treatment.\n\nRapid Viral Load Reduction: Clinical studies indicate that Favipiravir can significantly decrease viral replication rates, thereby reducing the duration and severity of symptoms.\n\nPotential to Limit Disease Progression: Early treatment with Favipiravir may prevent progression to severe disease stages, especially in viral respiratory infections such as COVID-19.\n\nEmergency and Compassionate Use Flexibility: During health crises, Favipiravir has been approved under emergency use protocols, making it accessible when other options are limited.\n\nPotential Side Effects of Favipiravir 200mg\nWhile Favipiravir is generally well-tolerated, users should be aware of possible side effects. Reported adverse effects range from mild to moderate in severity and often resolve after treatment completion:\n\nGastrointestinal Disturbances: Nausea, vomiting, diarrhea, and abdominal discomfort may occur but are usually transient.\n\nElevated Liver Enzymes: Temporary increases in liver function tests have been reported, necessitating monitoring especially in patients with preexisting liver conditions.\n\nElevated Uric Acid Levels: Favipiravir can cause hyperuricemia; monitoring uric acid levels is advisable during treatment.\n\nHypersensitivity Reactions: Rare cases of allergic reactions, including rash, itching, or swelling, have been documented.\n\nTeratogenicity and Contraindications in Pregnancy: Favipiravir is contraindicated in pregnant women or those planning pregnancy due to potential risks of fetal harm observed in animal studies.\n\nPatients should inform their healthcare providers of all preexisting conditions and concomitant medications to avoid drug interactions and complications. Routine blood tests may be conducted to monitor liver function and uric acid levels during therapy.\n\nConclusion\nFavipiravir 200mg serves as a vital antiviral agent with broad-spectrum activity against RNA viruses, playing a significant role in managing viral infections like influenza and COVID-19. Its ability to reduce viral replication rapidly and its oral administration mode make it a convenient and effective option, particularly in outpatient or emergency settings. While side effects are generally manageable, careful patient monitoring ensures safe use, especially in vulnerable populations.\n\nAs viral epidemics and pandemics continue to challenge global health, Favipiravir remains an important therapeutic tool, helping to curb disease progression and improve patient outcomes. Consulting a healthcare professional before starting Favipiravir treatment is essential to determine appropriateness, dosage, and duration based on individual health status and specific viral infection.", "price": 1786.0, "discountamount": 536.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2238, "imageuri": "https://productimages.withfloats.com/actual/6937c2a56743e47449a24df1.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6937c2a56743e47449a24df1.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-09T06:33:06.62Z", "updatedon": "2026-03-14T05:32:07.299Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//favipiravir-200mg/2238", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FAVIPRIVE 200", "category": "GENERAL RANGE", "tags": [ "Favipiravir 200mg", "RNA viruses", "Favipiravir 200mg", "COVID-19", "respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Favipiravir targets a wide array of RNA viruses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad74702e53c888beeab308d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets", "description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n", "price": 210.0, "discountamount": 147.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2505, "imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:48:34.116Z", "updatedon": "2026-10-20T10:48:34.116Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 10", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a057d8bd63de57b5424b7eb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Molnupiravir 200mg", "description": "Molnupiravir 200mg is an oral antiviral medication widely used in the management of mild to moderate viral infections caused by SARS-CoV-2, the virus responsible for COVID-19. It is designed to reduce the replication of the virus inside the human body, thereby helping in faster recovery and lowering the risk of severe complications when used at the early stage of infection.\n\nThis medicine gained significant attention during the COVID-19 pandemic as an effective oral treatment option, especially for patients who do not require hospitalization but still need antiviral therapy. Molnupiravir 200mg is typically prescribed under medical supervision and is used as part of a complete treatment plan based on patient condition and clinical evaluation.\n\nWhat is Molnupiravir 200mg?\n\nMolnupiravir is an antiviral prodrug that works by interfering with the replication process of viruses. Once inside the body, it is converted into an active form that introduces errors into viral RNA, preventing the virus from multiplying effectively.\n\nThis mechanism helps reduce viral load in the early phase of infection, which can limit disease progression and improve recovery outcomes.\n\nUses of Molnupiravir 200mg\n\nMolnupiravir 200mg is primarily used for:\n\nTreatment of mild to moderate COVID-19\nReducing viral load in infected patients\nPreventing progression of infection in high-risk individuals\nSupporting early-stage antiviral therapy\nReducing chances of hospitalization when taken timely\n\nIt is generally recommended for adult patients who have tested positive and are experiencing early symptoms.\n\nHow Molnupiravir Works (Mechanism of Action)\n\nMolnupiravir works by targeting viral RNA replication. After ingestion, it converts into an active metabolite that integrates into the viral RNA chain during replication.\n\nInstead of allowing the virus to copy itself accurately, it causes “copying errors” in the genetic structure of the virus. This process is known as viral mutagenesis, which ultimately weakens the virus and stops its spread inside the body.\n\nBecause of this mechanism, the viral load decreases over time, helping the immune system fight the infection more effectively.\n\nBenefits of Molnupiravir 200mg\n\nMolnupiravir offers several clinically important benefits when used appropriately:\n\n1. Early Viral Control\n\nIt helps reduce viral replication in the initial stage of infection.\n\n2. Oral Administration Convenience\n\nBeing an oral tablet, it can be taken at home without the need for hospitalization.\n\n3. Reduces Disease Progression\n\nEarly use may help prevent worsening of symptoms in high-risk patients.\n\n4. Supports Faster Recovery\n\nBy lowering viral load, it may contribute to quicker symptom relief.\n\n5. Suitable for Outpatient Treatment\n\nIt is often used for patients who are stable but need antiviral support.\n\nDosage and Administration\n\nThe dosage of Molnupiravir 200mg depends on the severity of infection and the doctor’s prescription.\n\nGeneral guidelines (for informational purposes only):\n\nUsually taken orally twice daily\nTreatment duration commonly lasts for 5 days\nShould be taken with or without food\nTablets should be swallowed whole with water\n\nIt is very important to complete the full prescribed course even if symptoms improve early.\n\n⚠️ Always follow medical advice before starting or stopping this medication.\n\nSide Effects of Molnupiravir 200mg\n\nLike all medicines, Molnupiravir may cause some side effects, although not everyone experiences them.\n\nCommon side effects:\nHeadache\nNausea\nDiarrhea\nDizziness\nFatigue\nLess common effects:\nSkin rash\nMild allergic reactions\nGastrointestinal discomfort\n\nIf any severe or unusual reaction occurs, immediate medical attention should be sought.\n\nPrecautions and Warnings\n\nBefore using Molnupiravir 200mg, certain precautions must be considered:\n\nNot recommended for use during pregnancy unless advised by a doctor\nBreastfeeding women should consult a healthcare professional\nPatients with severe liver or kidney conditions should use with caution\nNot intended for prevention of infection (only treatment)\nShould only be used after confirmed diagnosis\n\nIt is important not to self-medicate, as improper use may reduce effectiveness or cause unwanted effects.\n\nWho Should Avoid Molnupiravir?\n\nMolnupiravir may not be suitable for:\n\nPregnant women (unless specifically prescribed)\nChildren and adolescents under 18 years\nIndividuals allergic to any ingredient in the formulation\nPatients without confirmed viral infection\n\nMedical consultation is essential before starting treatment.\n\nStorage Instructions\n\nProper storage helps maintain the effectiveness of the medicine:\n\nStore at room temperature (below 30°C)\nKeep away from moisture and direct sunlight\nDo not freeze\nKeep out of reach of children\nUse before expiry date mentioned on packaging\nWhy Choose Molnupiravir 200mg Tablets?\n\nMolnupiravir 200mg is preferred in clinical practice due to its:\n\nProven antiviral action\nOral dosage convenience\nEarly-stage effectiveness\nSuitability for home-based treatment\nRole in reducing viral spread inside the body\n\nIt is an important supportive option in modern antiviral therapy protocols for viral respiratory infections.\n\nImportant Safety Note\n\nMolnupiravir should always be used under the supervision of a registered healthcare professional. Self-medication or incorrect dosage may reduce treatment effectiveness or lead to complications.\n\nThis medicine is part of a comprehensive treatment approach and should be combined with proper rest, hydration, and medical monitoring.\n\nConclusion\n\nMolnupiravir 200 mg is a clinically important antiviral medication used for managing mild to moderate cases of COVID-19. Its unique mechanism of action helps stop viral replication, reduce viral load, and support faster recovery when used at the right stage of infection.", "price": 2362.0, "discountamount": 708.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2420, "imageuri": "https://productimages.withfloats.com/actual/6a057d8df237845cd63444e2.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6a057d8df237845cd63444e2.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-14T07:45:15.983Z", "updatedon": "2026-05-23T08:35:26.503Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//molnupiravir-200mg/2420", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MOLNUPRIVE 200", "category": "GENERAL RANGE", "tags": [ "molnupiravir 200mg", "molnupiravir 200mg uses", "molnupiravir 200mg capsules", "tab molnupiravir 200mg", "molnupiravir 200mg tablet", "molnupiravir 200mg india", "molnupiravir 200mg price", "tab. molnupiravir 200mg", "Buy Molnupiravir 200mg Online", "COVID-19 Treatment Medicine Molnupiravir 200mg", "Molnupiravir 200mg Capsules for Viral Infection", "Molnupiravir 200mg Product Image", "Best Antiviral Medicine Molnupiravir 200mg", "Molnupiravir 200mg Capsules for COVID Treatment", "High Quality Molnupiravir 200mg Medicine", "Molnupiravir 200mg Pharma Product", "Molnupiravir 200mg Capsule Box Image", "Trusted Molnupiravir 200mg Antiviral Capsules" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69e0b33ed924338730097867", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "aspirin gastro resistant and rosuvastatin capsules ip uses", "description": "Introduction\n\nROUSTRIN AV 5 is a combination medication formulated to support heart health and reduce the risk of cardiovascular diseases. It contains two clinically proven ingredients: Aspirin 75 mg (gastro-resistant) and Rosuvastatin 5 mg. This dual-action capsule is widely prescribed for patients who are at risk of heart attack, stroke, or other cardiovascular complications.\n\nAspirin works as an antiplatelet agent, preventing blood clot formation, while Rosuvastatin belongs to the statin class of drugs that help lower cholesterol levels in the body. Together, they provide comprehensive protection by addressing both clot formation and lipid imbalance—two major causes of heart-related disorders.\n\nROUSTRIN AV 5 is especially beneficial for individuals with a history of heart disease, high cholesterol, hypertension, or diabetes. The gastro-resistant formulation ensures that Aspirin is released in the intestine rather than the stomach, reducing the risk of gastric irritation.\n\nUses of ROUSTRIN AV 5\n\nROUSTRIN AV 5 is commonly prescribed for the prevention and management of cardiovascular conditions. Its primary uses include:\n\nPrevention of heart attack (myocardial infarction)\nReduction in the risk of stroke\nManagement of high cholesterol (hyperlipidemia)\nPrevention of blood clot formation in arteries\nTreatment support for patients with coronary artery disease\nSecondary prevention in patients with previous cardiovascular events\n\nThis medication is often recommended as part of long-term therapy for maintaining heart health and preventing life-threatening complications.\n\nHow ROUSTRIN AV 5 Works\nAspirin 75 mg (Gastro-Resistant)\n\nAspirin inhibits platelet aggregation by blocking the production of thromboxane A2, a chemical responsible for blood clot formation. The gastro-resistant coating protects the stomach lining, ensuring safer long-term use.\n\nRosuvastatin 5 mg\n\nRosuvastatin reduces “bad cholesterol” (LDL) and triglycerides while increasing “good cholesterol” (HDL). It works by inhibiting the HMG-CoA reductase enzyme in the liver, which is responsible for cholesterol synthesis.\n\nTogether, these components reduce plaque formation in arteries and improve blood flow, significantly lowering the risk of cardiovascular events.\n\nKey Benefits of ROUSTRIN AV 5\n1. Dual Protection for Heart Health\n\nCombines antiplatelet and cholesterol-lowering actions, offering comprehensive cardiovascular protection.\n\n2. Reduces Risk of Heart Attack and Stroke\n\nHelps prevent clot formation and arterial blockage, which are major causes of heart attacks and strokes.\n\n3. Effective Cholesterol Management\n\nLowers LDL cholesterol and improves lipid profile, reducing long-term cardiovascular risk.\n\n4. Gastro-Resistant Formula\n\nMinimizes stomach irritation and enhances patient compliance during long-term use.\n\n5. Suitable for High-Risk Patients\n\nIdeal for patients with diabetes, hypertension, obesity, or family history of heart disease.\n\n6. Improves Blood Circulation\n\nPrevents clot formation and maintains smooth blood flow throughout the body.\n\nDosage and Administration\n\nROUSTRIN AV 5 should be taken strictly as prescribed by a healthcare professional.\n\nUsually taken once daily\nSwallow the capsule whole with water\nDo not crush or chew the capsule\nPreferably taken at the same time each day for best results\nCan be taken with or without food\n\nIt is important to follow the prescribed dosage and not discontinue the medication without consulting your doctor, even if you feel well.\n\nSide Effects of ROUSTRIN AV 5\n\nLike all medications, ROUSTRIN AV 5 may cause some side effects. Most are mild and temporary, but some may require medical attention.\n\nCommon Side Effects\nHeadache\nNausea or vomiting\nStomach discomfort\nMuscle pain\nWeakness\nLess Common Side Effects\nIndigestion\nDizziness\nConstipation\nIncreased liver enzymes\nSerious Side Effects (Seek Immediate Medical Help)\nUnusual bleeding or bruising\nSevere stomach pain or ulcers\nAllergic reactions (rash, swelling, difficulty breathing)\nSevere muscle pain (possible muscle breakdown)\nDark-colored urine or jaundice\n\nIf any unusual symptoms occur, it is important to consult a healthcare provider promptly.\n\nPrecautions and Warnings\n\nBefore using ROUSTRIN AV 5, consider the following precautions:\n\n1. Medical History\n\nInform your doctor if you have:\n\nLiver or kidney disease\nHistory of stomach ulcers or bleeding\nAsthma or allergy to Aspirin\nMuscle disorders\n2. Pregnancy and Breastfeeding\nNot recommended during pregnancy unless prescribed\nConsult a doctor before use during breastfeeding\n3. Alcohol Consumption\n\nAvoid excessive alcohol intake as it may increase the risk of liver damage and stomach bleeding.\n\n4. Drug Interactions\n\nROUSTRIN AV 5 may interact with:\n\nBlood thinners (warfarin, heparin)\nOther NSAIDs\nCertain antibiotics\nAntifungal medications\n\nAlways inform your doctor about all medications and supplements you are taking.\n\n5. Regular Monitoring\n\nPatients may require periodic monitoring of:\n\nLiver function\nLipid profile\nKidney function\nStorage Instructions\nStore in a cool, dry place\nKeep away from direct sunlight\nKeep out of reach of children\nDo not use after the expiry date\nConclusion\n\nROUSTRIN AV 5 (Aspirin 75 mg Gastro-Resistant & Rosuvastatin 5 mg Capsules) is a highly effective combination therapy designed to protect heart health and prevent serious cardiovascular conditions. By combining the blood-thinning action of Aspirin with the cholesterol-lowering effect of Rosuvastatin, it provides a comprehensive solution for individuals at risk of heart disease.", "price": 125.0, "discountamount": 37.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2381, "imageuri": "https://productimages.withfloats.com/actual/69e0b3da7207f3415693ca4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69e0b3da7207f3415693ca4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-16T10:00:30.807Z", "updatedon": "2026-04-17T09:44:14.825Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//aspirin-gastro-resistant-and-rosuvastatin-capsules-ip-uses/2381", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROUSTRIN AV 5", "category": "CARDIOLOGYRANGE", "tags": [ "rosuvastatin 5 mg", "rosuvastatin 5 mg uses", "rosuvastatin 5 mg uses in hindi", "rosuvastatin 5 mg price", "rosuvastatin 5 mg price in india", "is rosuvastatin 5 mg safe to take", "aspirin 75 mg", "aspirin 75 mg uses", "aspirin 75 mg price", "aspirin 75 mg uses", "aspirin gastro resistant and rosuvastatin capsules ip uses", "aspirin gastro resistant and rosuvastatin capsules", "aspirin gastro resistant and rosuvastatin capsules uses", "aspirin gastro resistant and rosuvastatin", "aspirin gastro resistant and rosuvastatin capsule" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69ce28ce7523e3729e781723", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "tiapride hydrochloride tablets", "description": "TIAPRADE 50 tablets, containing Tiapride Hydrochloride 50mg, offer targeted relief for behavioral disorders and movement issues. This atypical antipsychotic helps manage symptoms like agitation and dyskinesia effectively.\n\nProduct Description\nTIAPRADE 50 is a prescription medication featuring Tiapride Hydrochloride as its active ingredient, each tablet delivering precisely 50mg of this compound. Manufactured to high pharmaceutical standards, these tablets are designed for oral administration, typically taken with water after meals to enhance absorption and minimize stomach upset. Tiapride belongs to the class of selective dopamine D2 and D3 receptor antagonists, distinguishing it from typical antipsychotics by its lower risk of extrapyramidal side effects. This makes TIAPRADE 50 particularly suitable for vulnerable populations, including the elderly.\n\nThe tablets are compact, film-coated for easy swallowing, and come in blister packs that protect against moisture and light. As a non-sedating option in many cases, TIAPRADE 50 supports daily functioning without excessive drowsiness, aligning with modern psychiatric care needs. For SEO optimization targeting “Tiapride Hydrochloride Tablets” or “TIAPRADE 50 uses,” this product stands out for its versatility in treating neuropsychiatric conditions.\n\nKey Uses and Applications\nTIAPRADE 50 excels in managing a range of psychiatric and neurological conditions rooted in dopamine imbalance. Primarily, it treats schizophrenia by controlling negative symptoms such as social withdrawal, lack of emotion, and poor concentration, helping patients reintegrate into society.\n\nIt is highly effective for behavioral disorders, including agitation, aggression, and impulsivity, especially in elderly patients with dementia or alcohol withdrawal syndrome. Clinically, TIAPRADE 50 addresses dyskinesia—involuntary movements of limbs or face—often linked to Parkinson's disease or long-term antipsychotic use. Other applications include Tourette's syndrome, tics, chorea in Huntington's disease, and even acute alcohol dependence delirium tremens.\n\nIn hospital settings, such as during COVID-19-related agitation, TIAPRADE 50 has shown promise due to its favorable safety profile. Dosage typically starts at 100-200mg three times daily (2-4 tablets of TIAPRADE 50), adjustable up to 600mg/day based on severity, age, and response. Full effects may take 4-6 weeks, so consistent use under medical supervision is essential.\n\nHow TIAPRADE 50 Works\nTIAPRADE 50 modulates dopamine activity in the brain's limbic system, blocking overactive D2 receptors without strongly affecting other neurotransmitters like serotonin or histamine. This selective action reduces psychotic symptoms, calms agitation, and suppresses abnormal movements while preserving cognitive function.\n\nUnlike broader antipsychotics, Tiapride's mechanism minimizes motor side effects, making it ideal for long-term dyskinesia management. It stabilizes mood swings in mania or schizophrenia, promoting clearer thinking and emotional balance. Patients often report improved sleep patterns and reduced anxiety within days, though optimal benefits build gradually.\n\nFor “Tiapride Hydrochloride Tablets mechanism,” this targeted dopamine inhibition underpins its efficacy across disorders, supported by decades of clinical data.\n\nKey Benefits\nTIAPRADE 50 delivers multifaceted benefits, enhancing quality of life for those with psychiatric challenges.\n\nRapid Symptom Control: Quickly reduces agitation and aggression, vital for elderly care or acute episodes.\n\nLow Extrapyramidal Risk: Unlike older antipsychotics, it rarely causes stiffness or tremors, ideal for dyskinesia patients.\n\nElderly-Friendly: Mild sedation profile supports geriatric use without impairing mobility or cognition.\n\nVersatile for Comorbidities: Effective in alcohol withdrawal, tics, and schizophrenia, reducing polypharmacy needs.\n\nImproved Daily Functioning: Boosts social engagement, attention, and emotional expression in psychosis.\n\nStudies affirm its tolerability, with many patients tolerating doses up to 600 mg daily long-term. Benefits extend to headache relief in some neurological cases and better outcomes in Tourette's management.\n\nBenefit\tTarget Condition\tAdvantage Over Alternatives\nAgitation Reduction\tElderly Behavioral Disorders\tLess sedation than benzodiazepines \nDyskinesia Control\tParkinson's-Related\tMinimal motor worsening \nNegative Symptom Relief\tSchizophrenia\tPreserves cognition \nWithdrawal Support\tAlcohol Dependence\tSafer in delirium tremens \nPotential Side Effects\nWhile generally well-tolerated, TIAPRADE 50 may cause mild, transient side effects that resolve with time or dose adjustment.\n\nCommon effects include drowsiness, dizziness, headache, insomnia, fatigue, and agitation—often fading after the first week. Less frequent are tremor, increased salivation, vertigo, orthostatic hypotension (dizziness on standing), and emotional blunting.\n\nRarely, overdose risks low blood pressure, sedation, or convulsions; seek immediate help if suspected. Avoid abrupt cessation to prevent rebound symptoms. Most resolve without intervention, but persistent issues warrant medical review.\n\nContraindications and Precautions\nDo not use TIAPRADE 50 if you have prolactinoma, pheochromocytoma, severe kidney/liver disease, heart conditions, convulsions history, or allergies to Tiapride. It's contraindicated in pregnancy, breastfeeding, children under 15, and those with epilepsy.\n\nPrecautions include monitoring prolactin levels, blood pressure, and liver function. Avoid alcohol, as it amplifies sedation. Drive cautiously until the effects are known. Drug interactions with antihypertensives or CNS depressants require dose tweaks.\n\nDosage Guidelines\nStart with 50-100mg (1-2 TIAPRADE 50 tablets) three times daily, post-meals. Maximum 600mg/day for adults; elderly may need lower doses (300mg/day). Adjust per response, not exceeding 4-6 weeks without reassessment. Swallow whole; store below 30°C.\n\nConclusion\nTIAPRADE 50 (Tiapride Hydrochloride Tablets 50 mg) stands as a reliable, SEO-highlighted solution for agitation, dyskinesia, schizophrenia, and behavioral disorders, balancing efficacy with safety. Its dopamine-selective action delivers key benefits like symptom control and preserved function, outweighing manageable side effects for suitable patients. Consult your doctor to integrate TIAPRADE 50 into your care plan for optimal mental health outcomes—empowering calmer, more productive lives.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2362, "imageuri": "https://productimages.withfloats.com/actual/69ce28d0b438828e202fff3f.png", "tileimageuri": "https://productimages.withfloats.com/tile/69ce28d0b438828e202fff3f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-02T08:29:02.247Z", "updatedon": "2026-04-02T08:29:02.247Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tiapride-hydrochloride-tablets/2362", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TIAPRADE 50", "category": "NEUROLOGYRANGE", "tags": [ "tiapride hydrochloride tablets uses in hindi", "tiapride 50 mg tablets wholesale supplier", "tiapride tablet for anxiety and stress", "tiapride tablets india uses and price", "tiapride tablets for neurological disorders", "tiapride hydrochloride tablets 50 mg uses and side effects", "tiapride hydrochloride tablets b2b supplier" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69623e6c95697555dd1afd67", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Esomeprazole and Itopride", "description": "ESMOSTRUM IT: Comprehensive Product Guide\nProduct Overview\nESMOSTRUM IT is an advanced pharmaceutical formulation that combines two potent active ingredients—Esomeprazole and Itopride—to provide comprehensive relief from gastrointestinal disorders. This dual-action medication represents a significant advancement in the management of acid-related digestive conditions and motility disorders. By combining a proton pump inhibitor with a prokinetic agent, ESMOSTRUM IT addresses both the underlying causes and symptomatic manifestations of various digestive ailments, offering patients a complete therapeutic solution in a single, convenient dosage form.\nThe synergistic combination of Esomeprazole and Itopride makes ESMOSTRUM IT particularly effective for individuals suffering from gastroesophageal reflux disease (GERD), functional dyspepsia, and other conditions where both excessive acid production and impaired gastric motility contribute to discomfort and disease progression.\nActive Pharmaceutical Ingredients\nEsomeprazole\nEsomeprazole is the S-isomer of omeprazole and belongs to the class of medications known as proton pump inhibitors (PPIs). It works by specifically and irreversibly blocking the hydrogen-potassium adenosine triphosphatase enzyme system (the proton pump) located in the gastric parietal cells. This mechanism effectively reduces gastric acid secretion, providing sustained relief from acid-related symptoms and allowing damaged esophageal and gastric tissue to heal.\nItopride\nItopride is a prokinetic agent that enhances gastrointestinal motility through a dual mechanism of action. It acts as both a dopamine D2 receptor antagonist and an acetylcholinesterase inhibitor. By blocking dopamine receptors, it removes the inhibitory effect of dopamine on gastrointestinal motility, while its acetylcholinesterase inhibition increases acetylcholine levels, further promoting coordinated gastric contractions and improved gastric emptying.\nTherapeutic Uses and Indications\nESMOSTRUM IT is prescribed for a wide range of gastrointestinal conditions where both acid suppression and enhanced motility are therapeutically beneficial:\nGastroesophageal Reflux Disease (GERD)\nESMOSTRUM IT provides exceptional relief for patients suffering from GERD, a chronic condition where stomach acid frequently flows back into the esophagus. The esomeprazole component reduces acid production, while itopride improves the tone of the lower esophageal sphincter and accelerates gastric emptying, thereby reducing the frequency and severity of reflux episodes.\nFunctional Dyspepsia\nFor patients experiencing persistent or recurrent upper abdominal discomfort without an identifiable organic cause, ESMOSTRUM IT addresses multiple pathophysiological mechanisms. It relieves symptoms such as early satiety, postprandial fullness, epigastric pain, and bloating by normalizing gastric acid levels and improving gastric accommodation and emptying.\nPeptic Ulcer Disease\nESMOSTRUM IT aids in the healing of gastric and duodenal ulcers by creating an optimal healing environment through sustained acid suppression. The prokinetic action of itopride helps prevent stasis of gastric contents, which can exacerbate ulcer symptoms.\nNon-Ulcer Dyspepsia\nMany patients experience dyspeptic symptoms without evidence of ulceration. ESMOSTRUM IT effectively manages these symptoms by addressing both acid hypersecretion and delayed gastric emptying, two key factors in non-ulcer dyspepsia.\nGastroparesis-Related Symptoms\nIn conditions where gastric emptying is significantly delayed, the itopride component of ESMOSTRUM IT helps restore more normal gastric motility patterns, reducing associated symptoms like nausea, vomiting, and abdominal distension.\nKey Benefits and Advantages\nDual Mechanism of Action\nThe primary advantage of ESMOSTRUM IT lies in its comprehensive approach to gastrointestinal health. Rather than addressing only acid production or motility in isolation, this combination therapy tackles both aspects simultaneously, providing more complete symptom relief and better therapeutic outcomes.\nSuperior Acid Suppression\nEsomeprazole offers more consistent and prolonged acid suppression compared to many other acid-reducing medications. It provides sustained relief throughout the day and night, allowing patients to experience fewer breakthrough symptoms and better quality of life.\nEnhanced Gastric Motility\nThe itopride component specifically targets motility issues without crossing the blood-brain barrier significantly, meaning it provides prokinetic benefits with minimal central nervous system side effects. This results in improved gastric emptying, reduced bloating, and decreased feelings of fullness after meals.\nRapid Symptom Relief\nMany patients experience noticeable improvement in their symptoms within the first few days of treatment with ESMOSTRUM IT. The combination therapy addresses multiple symptom pathways simultaneously, leading to faster and more comprehensive relief.\nImproved Quality of Life\nBy effectively managing symptoms such as heartburn, regurgitation, nausea, bloating, and early satiety, ESMOSTRUM IT significantly enhances patients' daily functioning and overall well-being. Patients report better sleep quality, improved dietary tolerance, and reduced anxiety related to their digestive symptoms.\nConvenient Dosing\nThe combination of two active ingredients in a single formulation improves medication adherence by reducing pill burden. Patients appreciate the simplicity of taking one medication instead of multiple separate preparations.\nMucosal Healing Properties\nBeyond symptom relief, ESMOSTRUM IT promotes actual healing of damaged esophageal and gastric mucosa. The reduced acid environment created by esomeprazole allows inflamed and eroded tissue to regenerate properly.\nReduced Risk of Complications\nBy effectively controlling acid reflux and improving gastric emptying, ESMOSTRUM IT helps prevent potential complications of chronic GERD, such as esophageal strictures, Barrett's esophagus, and respiratory complications from aspiration.\nDosage and Administration\nESMOSTRUM IT should be taken exactly as prescribed by a healthcare professional. Typically, the medication is administered orally, preferably before meals to optimize its therapeutic effects. The standard dosing regimen usually involves once or twice daily administration, though individual requirements may vary based on the severity of the condition and patient response.\nThe medication should be swallowed whole with water and should not be crushed, chewed, or split, as this may affect the drug's release mechanism and therapeutic efficacy. Patients should maintain regular dosing schedules to ensure optimal acid suppression and motility enhancement throughout the day.\nSide Effects and Safety Considerations\nLike all medications, ESMOSTRUM IT may cause side effects in some individuals, though not everyone experiences them. Understanding potential adverse effects helps patients identify and report concerning symptoms promptly.\nCommon Side Effects\nGastrointestinal Effects: Some patients may experience diarrhea, constipation, abdominal pain, nausea, or flatulence, particularly during initial treatment. These effects are usually mild and often resolve as the body adjusts to the medication.\nHeadache: Mild to moderate headaches occur in a small percentage of patients and typically diminish with continued use.\nDizziness: Some individuals may experience lightheadedness or dizziness, particularly when standing up quickly.\nDry Mouth: Reduced saliva production may occur, leading to oral dryness and discomfort.\nLess Common Side Effects\nSkin Reactions: Rash, itching, or other dermatological manifestations may develop in sensitive individuals.\nSleep Disturbances: Some patients report insomnia or unusual dreams while taking the medication.\nIncreased Prolactin Levels: Itopride may cause mild elevation in prolactin levels, though clinical manifestations are rare.\nTaste Alterations: Changes in taste perception or metallic taste may occur temporarily.\nSerious Side Effects (Rare)\nWhile uncommon, certain serious adverse effects require immediate medical attention:\n\nSevere allergic reactions including difficulty breathing, facial swelling, or severe skin reactions\nSevere diarrhea that persists or contains blood\nIrregular heartbeat or palpitations\nMuscle weakness or pain\nSeizures or tremors\nSigns of liver problems including jaundice, dark urine, or persistent nausea\n\nLong-Term Considerations\nExtended use of proton pump inhibitors like esomeprazole has been associated with certain risks that patients should discuss with their healthcare providers:\n\nPotential reduction in calcium, magnesium, and vitamin B12 absorption\nSlightly increased risk of bone fractures with prolonged use\nPossible increased susceptibility to certain gastrointestinal infections\nRare cases of kidney problems\n\nRegular monitoring and periodic assessment by healthcare professionals help minimize these risks while maintaining therapeutic benefits.\nPrecautions and Contraindications\nPatients should inform their healthcare provider about all existing medical conditions, particularly liver disease, kidney problems, osteoporosis, low magnesium levels, or any gastrointestinal bleeding. ESMOSTRUM IT may interact with certain medications, including blood thinners, antifungals, HIV medications, and certain antibiotics. A complete medication review ensures safe and effective therapy.\nPregnant or breastfeeding women should only use ESMOSTRUM IT under strict medical supervision, as the safety profile in these populations requires careful consideration of potential risks and benefits.\nLifestyle Recommendations\nFor optimal therapeutic outcomes, patients taking ESMOSTRUM IT should complement their medication regimen with appropriate lifestyle modifications:\n\nAvoid trigger foods that exacerbate acid reflux, such as spicy foods, citrus, chocolate, caffeine, and alcohol\nMaintain a healthy body weight to reduce abdominal pressure\nEat smaller, more frequent meals rather than large portions\nAvoid lying down immediately after eating; wait at least two to three hours\nElevate the head of the bed if nighttime symptoms occur\nQuit smoking, as tobacco use significantly worsens reflux symptoms\nManage stress through relaxation techniques, as stress can exacerbate digestive symptoms\n\nConclusion\nESMOSTRUM IT represents a sophisticated and effective pharmaceutical solution for individuals struggling with complex gastrointestinal disorders involving both acid hypersecretion and impaired motility. By combining the powerful acid-suppressing capabilities of esomeprazole with the prokinetic benefits of itopride, this medication offers comprehensive symptom management that addresses the multifaceted nature of digestive disorders.", "price": 182.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2273, "imageuri": "https://productimages.withfloats.com/actual/69623e6fd8491171373812e3.png", "tileimageuri": "https://productimages.withfloats.com/tile/69623e6fd8491171373812e3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T11:56:28.061Z", "updatedon": "2026-04-21T09:38:56.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//esomeprazole-and-itopride/2273", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ESMOSTRUM IT", "category": "GASTROLOGYRANGE", "tags": [ "esomeprazole and itopride", "esomeprazole and itopride capsules uses in hindi", "esomeprazole and itopride capsules uses", "esomeprazole and itopride brand name", "esomeprazole and itopride hydrochloride", "esomeprazole and itopride capsules", "esomeprazole and itopride uses", "esomeprazole and itopride hydrochloride capsules", "esomeprazole and itopride hydrochloride uses", "esomeprazole and itopride hydrochloride price", "esomeprazole and itopride hydrochloride price in india", "buy online Esomeprazole and Itopride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }